HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Adriano Piris Selected Research
Adriano Piris Research Topics
Disease
26
Neoplasms (Cancer)
01/2024 - 10/2002
21
Melanoma (Melanoma, Malignant)
01/2022 - 10/2002
3
Nevus (Nevi)
09/2015 - 12/2009
3
Neoplasm Metastasis (Metastasis)
05/2014 - 08/2010
3
Carcinoma (Carcinomatosis)
05/2014 - 04/2009
2
Renal Cell Carcinoma (Grawitz Tumor)
06/2015 - 02/2015
2
Acrospiroma
08/2010 - 04/2009
2
Lymphatic Metastasis
06/2006 - 05/2003
1
Wounds and Injuries (Trauma)
01/2024
1
Hypersensitivity (Allergy)
01/2024
1
Virus Diseases (Viral Diseases)
01/2024
1
Skin Neoplasms (Skin Cancer)
01/2021
1
Merkel Cell Carcinoma
01/2020
1
Neuroendocrine Carcinoma
01/2020
1
Residual Neoplasm
01/2018
1
Disease Progression
01/2018
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2016
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2016
1
Pigmented Nevus (Melanocytic Nevus)
09/2015
1
Neuroblastoma
09/2015
1
Adenocarcinoma of Lung
06/2015
1
Uveal melanoma
02/2015
1
Colorectal Neoplasms (Colorectal Cancer)
03/2012
1
Carcinogenesis
01/2012
1
Infections
07/2011
1
Nevi and Melanomas
10/2010
1
Leukemia
07/2009
Drug/Important Bio-Agent (IBA)
7
Antigens
IBA
01/2022 - 05/2003
5
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2018 - 01/2012
5
Proteins (Proteins, Gene)
FDA Link
01/2016 - 10/2004
4
Vemurafenib
IBA
01/2018 - 01/2012
3
Vaccines
IBA
01/2024 - 10/2002
2
Histones (Histone)
IBA
01/2022 - 04/2009
2
Cohesins
IBA
01/2022 - 01/2016
2
RNA (Ribonucleic Acid)
IBA
01/2022 - 01/2018
2
Cytokines
IBA
01/2018 - 07/2014
2
Sorafenib (BAY 43-9006)
FDA Link
03/2016 - 01/2012
2
Proto-Oncogene Proteins c-akt (Protein Kinase B)
IBA
01/2016 - 09/2015
2
Immune Checkpoint Inhibitors
IBA
07/2014 - 03/2013
2
Keratin-5 (Keratin 5)
IBA
05/2014 - 02/2014
2
Ligands
IBA
03/2013 - 12/2007
2
ErbB Receptors (EGF Receptor)
IBA
08/2010 - 04/2009
2
vitespin
IBA
08/2006 - 10/2002
2
Heat-Shock Proteins (Heat-Shock Protein)
IBA
08/2006 - 10/2002
1
DNA (Deoxyribonucleic Acid)
IBA
01/2022
1
Lysine (L-Lysine)
FDA Link
01/2022
1
Interferons
IBA
01/2022
1
gamma Subunit Interferon-Stimulated Gene Factor 3 (Interferon Stimulated Gene Factor 3, gamma Subunit)
IBA
01/2022
1
Paraffin
IBA
01/2021
1
Viral DNA
IBA
01/2020
1
Tumor Viral Antigens (Large T Antigen)
IBA
01/2020
1
Circular DNA
IBA
01/2020
1
Interleukin-2 (IL2)
IBA
01/2018
1
aldesleukin (Proleukin)
FDA Link
01/2018
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
01/2016
1
Mutant Proteins (Protein, Mutant)
IBA
01/2016
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
09/2015
1
Ubiquitin
IBA
06/2015
1
Ligases (Synthetase)
IBA
06/2015
1
Microphthalmia-Associated Transcription Factor
IBA
06/2015
1
cediranib (AZD2171)
IBA
01/2015
1
PLX 4720
IBA
01/2015
1
Dactinomycin (Actinomycin)
FDA Link
Generic
09/2014
1
Desmin
IBA
09/2014
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
09/2014
1
Myogenin
IBA
09/2014
1
Vincristine (Oncovin)
FDA Link
Generic
09/2014
1
atezolizumab
IBA
07/2014
1
Estrogen Receptors
IBA
02/2014
1
Progesterone Receptors (Progesterone Receptor)
IBA
02/2014
1
Perilipin-2
IBA
02/2014
1
Androgen Receptors (Androgen Receptor)
IBA
02/2014
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
10/2013
1
Complementarity Determining Regions (Complementarity Determining Region)
IBA
10/2013
1
Mitogens
IBA
07/2013
1
Mitogen-Activated Protein Kinases
IBA
07/2013
1
Phosphotransferases (Kinase)
IBA
07/2013
1
Protein Kinases (Protein Kinase)
IBA
07/2013
1
Mechanistic Target of Rapamycin Complex 1
IBA
07/2013
1
Biomarkers (Surrogate Marker)
IBA
07/2013
1
Ribosomal Protein S6
IBA
07/2013
1
dabrafenib
IBA
03/2013
1
Dihydrotachysterol (AT 10)
IBA
03/2013
1
trametinib
IBA
03/2013
1
Valine (L-Valine)
FDA Link
03/2012
1
Calcibiotic Root Canal Sealer
IBA
03/2012
1
V 70 (V70)
IBA
01/2012
1
posaconazole
FDA Link
07/2011
1
Collagen
IBA
12/2009
1
Interferon-alpha (Interferon Alfa)
IBA
08/2006
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
08/2006
1
Enzymes
IBA
08/2006
1
Peptides (Polypeptides)
IBA
08/2006
1
Caspases
IBA
10/2004
Therapy/Procedure
11
Therapeutics
01/2018 - 06/2006
2
Drug Therapy (Chemotherapy)
09/2014 - 07/2009
2
Immunotherapy
03/2013 - 05/2003
1
Mohs Surgery (Mohs' Micrographic Surgery)
01/2021
1
Aftercare (After-Treatment)
07/2013
1
Transjugular Intrahepatic Portasystemic Shunt
10/2010